Iacopo Olivotto, MD - A New Chapter in Hypertrophic Cardiomyopathy Management: Updates From the European Society of Cardiology (ESC) 2023 Guidelines and New Treatment Options CME in Minutes: Education in Cardiology & Pulmonology

Please visit answersincme.com/PKW860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in cardiology discusses guideline and treatment updates for the management of hypertrophic cardiomyopathy, and the clinical implications of recent data on novel cardiac myosin inhibitors. Upon completion of this activity, participants should be better able to: Outline the latest guideline updates for diagnosis and treatment of obstructive HCM; Review strategies to facilitate the early diagnosis of obstructive HCM; and Recognize the clinical significance of the latest data on cardiac myosin inhibitors for the treatment of obstructive HCM.